Salem Investment Counselors Inc. purchased a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 66,530 shares of the biotechnology company’s stock, valued at approximately $1,238,000. Salem Investment Counselors Inc. owned approximately […]